Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

28.52
-0.2000-0.70%
Post-market: 28.590.0700+0.25%19:59 EDT
Volume:33.64M
Turnover:964.55M
Market Cap:162.16B
PE:37.53
High:28.95
Open:28.79
Low:28.52
Close:28.72
52wk High:29.21
52wk Low:23.62
Shares:5.69B
Float Shares:5.64B
Volume Ratio:1.09
T/O Rate:0.60%
Dividend:1.72
Dividend Rate:6.03%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.90
PE(LYR):20.90

Loading ...

Medicus Pharma - Pfizer Paid the Company a One-Time, Non-Refundable Payment of $2.0 Million

THOMSON REUTERS
·
Sep 03

Medicus Pharma - Enters Co-Development and License Agreement with Pfizer on Sept 2, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 03

NYSE Most Active Issues

Dow Jones
·
Sep 03

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 03

Pfizer’s New Asthma Candidate PF-08103402 Enters Phase 1: What Investors Should Know

TIPRANKS
·
Sep 03

Top AI Healthcare Stocks For September 2026

Simply Wall St.
·
Sep 02

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

Simply Wall St.
·
Sep 02

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Did Targeted XFG COVID Shots Just Recenter Pfizer's (PFE) Post‑Pandemic Investment Narrative?

Simply Wall St.
·
Sep 01

NYSE Most Active Issues

Dow Jones
·
Sep 01

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Trump Administration Announces Drug Pricing Deals with CSL, Astellas and Others

Reuters
·
Sep 01

Pfizer Pivots: New Trials Target Obesity, Cancer, Autoimmune

TIPRANKS
·
Aug 29

Pfizer EVP Cecile Guegan Files Initial Beneficial Ownership Statement

Reuters
·
Aug 29

Pfizer Extends Tucatinib Access With New Continuation Study: What Investors Should Know

TIPRANKS
·
Aug 29

Pfizer Expands Autoimmune Pipeline With New Early-Stage Trial of PF-08154225

TIPRANKS
·
Aug 29

Pfizer Targets China’s Obesity Market With New Phase 3 Berobenatide Trial

TIPRANKS
·
Aug 29

NYSE Most Active Issues

Dow Jones
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28

Pfizer and BioNTech receive FDA approval for XFG-adapted COVID-19 vaccine

TIPRANKS
·
Aug 28